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2000), and embryonic development of mice (Bullock et
al., 1998) and Drosophila (Tsuda et al., 1999). Sulfated
oligosaccharides present on L-selectin counterrecep-
tors have been implicated in lymphocyte homing and
recirculation, important processes in the detection of
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mucin-like domains that act as scaffolding for O-linked
oligosaccharides. The functionality of these L-selectin
counterreceptors is entirely dependent on their decora-Summary
tion with specific sialylated, fucosylated, and sulfated
oligosaccharides (Imai et al., 1993; Hemmerich et al.,L-selectin mediates lymphocyte homing by facilitating
1995; Maly et al., 1996). Recent studies demonstratedlymphocyte adhesion to addressins expressed in the
that either mouse or human L-selectin ligand sulfotransf-high endothelial venules (HEV) of secondary lymphoid
erase (LSST) enables the synthesis of a sulfated sialylorgans. Peripheral node addressin recognized by the
Lewis x (sLex), 6-sulfo sLex (NeuNAc2→3Gal1→MECA-79 antibody is apparently part of the L-selectin
4[Fuc1→3(sulfo→6)]GlcNAc), on core2 branched O-gly-ligand, but its chemical nature has been undefined.
cans (Bistrup et al., 1999; Hiraoka et al., 1999). LSST-We now identify a sulfated extended core1 mucin-type
dependent expression of this sulfated oligosaccharideO-glycan, Gal1→4(sulfo→6)GlcNAc1→3Gal1→
on CD34-associated O-glycans yields enhanced L-selec-3GalNAc, as the MECA-79 epitope. Molecular cloning
tin-dependent cell adhesion under shear, relative toof a HEV-expressed core1-1,3-N-acetylglucosami-
CD34 decorated with nonsulfated core2 type sLex li-nyltransferase (Core1-3GlcNAcT) enabled the con-
gands. By contrast, 6-sulfo sLex decorating CD34-asso-struction of the 6-sulfo sialyl Lewis x on extended
ciated N-glycans, conferred by a GlcNAc-6-O-sulfotran-core1 O-glycans, recapitulating the potent L-selectin-
sferase (GlcNAc6ST; Uchimura et al., 1998), does notmediated, shear-dependent adhesion observed with
support shear-dependent L-selectin ligand activity (Hi-
novel L-selectin ligands derived from core2 1,6-N-
raoka et al., 1999).
acetylglucosaminyltransferase-I null mice. These re- L-selectin counterreceptors on peripheral lymph node
sults identify Core1-3GlcNAcT and its cognate ex- HEVs in human and rodents include a heterogeneous
tended core1 O-glycans as essential participants in group of glycoproteins, termed peripheral node ad-
the expression of the MECA-79-positive, HEV-specific dressin (PNAd), which are recognized by the MECA-79
L-selectin ligands required for lymphocyte homing. monoclonal antibody (Streeter et al., 1988). MECA-79
specifically recognizes the luminal surface of HEV in
Introduction peripheral lymph nodes, and inhibits lymphocyte attach-
ment to HEV (Streeter et al., 1988; Clark et al., 1998).
Sulfated oligosaccharides play diverse roles in develop- Although there is evidence that the MECA-79-reactive
ment, differentiation, and homeostasis. They affect the molecule is a sulfated O-linked oligosaccharide (Hem-
binding of growth factors to receptors (Rapraeger et merich et al., 1994) distinct from 6-sulfo sLex in core2
al., 1991; Yayon et al., 1991), clearance of circulating O-glycans (Hiraoka et al., 1999), its precise chemical
glycoprotein hormones (Fiete et al., 1991), adhesion of structure has not been defined.
herpes simplex virus I to the cell surface (Shukla et al., Core2 branches are formed by core2 1,6-N-acetyl-
1999), formation of a transparent cornea (Akama et al., glucosaminyltransferases (Core2GlcNAcT; Bierhuizen
and Fukuda, 1992). While 6-sulfo sLex structures on
core2 branched O-linked oligosaccharides had been as-5 Correspondence: minoru@burnham.org
6 These two authors equally contributed to this work. signed roles in L-selectin ligand activity, deletion of
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Core2GlcNAcT-I in mice is associated with retention of gosaccharide a after removal of fucose (Figure 1E), and
then to core1 oligosaccharide, Gal1→3GalNAc, afterwild-type MECA-79 expression and normal lymphocyte
homing activities (Ellies et al., 1998). These results imply sequential glycosidase treatment (Figures 1F and 1G).
Methylation analysis of [3H]-galactose-labeled oligosac-either that other Core2GlcNAcTs (Core2GlcNAcT-II, Yeh
et al., 1999; Core2GlcNAcT-III, Schwientek et al., 2000) charides demonstrated that oligosaccharide b contains
both terminal and 3-O-substituted galactoses (Figure 1I)may compensate for loss of Core2GlcNAcT-I in HEV of
the mutant mice, or that oligosaccharides distinct from in contrast to core2 oligosaccharides, which contain
only terminal galactoses (Figure 1H). Together, thesecore2 branched oligosaccharides may function as
L-selectin ligands in HEV. results demonstrate that oligosaccharide b is Gal1→4
(Fuc1→3)GlcNAc1→3Gal1→3GalNAc. To determineTo address these issues, we have defined the oligo-
saccharide structures remaining in PNAd present in the positions of sialic acid and sulfate attachment, intact
oligosaccharides from Core2GlcNAcT-I mice were se-Core2GlcNAcT-I null mice (Core2GlcNAcT-I) and iden-
tify L-selectin ligands as sialylated and fucosylated quentially digested with specific glycosidases, includ-
ing -hexosaminidase A that cleaves both 6-sulfatedforms of a sulfated extended core1 O-glycan, Gal1→4
(sulfo→6)GlcNAc1→3Gal1→3GalNAc. Chemical syn- and unsulfated N-acetylglucosamine, producing core1
oligosaccharide (data not shown). These results takenthesis of this glycan led to the discovery that it cor-
responds to the MECA-79 epitope. A newly cloned, together demonstrate that sulfated, extended core1
oligosaccharides of NeuNAc2→3Gal1→4[Fuc1→3HEV-expressed core1 extension-1,3-N-acetylglucosami-
nyltransferase (Core1-3GlcNAcT) confers the expression (Sulfo→6)]GlcNAc1→3Gal1→3GalNAc constitute the
majority of the oligosaccharides elaborated by Core-of 6-sulfo sLex in the extended core1 oligosaccharides,
promoting potent L-selectin-dependent adhesion. Ex- 2GlcNAcT-I HEV. It is noteworthy that no core2 branched
oligosaccharides were detected.tended core 1-based L-selectin ligands are also im-
plicated as prominent L-selectin ligands expressed by
the HEV in wild-type since MECA-79 antibody treat- Isolation of cDNA Encoding Core1 Extending
ment significantly reduces the lymphocyte adhesion to 1,3-N-Acetylglucosaminyltransferase
GlyCAM-1 from wild-type mouse HEV. Core1-3GlcNAcT The identification of extended core1 glycans expressed
and its cognate extended core1 O-glycans therefore by Core2GlcNAcT-I HEV predicted the existence of a
play dominant roles in L-selectin ligand biosynthesis, relevant Core1-3GlcNAcT. Previous work demonstrating
lymphocyte homing, and lymphocyte trafficking. a weak but discernable homology among three 1,3-galac-
tosyltransferases (3GalT) and one 3GlcNAcT (Zhou et
al., 1999) led us to search the EST databases for cDNAsResults
related to 3GlcNAcT. One of these human cDNAs (EST
number AB015630), when coexpressed with humanCore2GlcNAcT-I-Deficient Mice Express
LSST, conferred expression of the MECA-79 antigen onExtended Core1 Structures
CHO cells (see below). The full-length sequence of thisAssays of Core2GlcNAcT activity demonstrated that
cDNA (deposited with GenBank with the accession num-lymph nodes of Core2GlcNAcT-I mice (Ellies et al.,
ber AF293973) encodes an open reading frame of 1,1161998) exhibited less than 4% of the Core2GlcNAcT activ-
base pairs and predicts a protein of 372 amino acidity exhibited by lymph nodes from wild-type mice. This
residues (42,514 Da). The protein is predicted to havereduction is as severe as that observed in the spleen
a type II membrane topology representative of virtuallyand much more significant than that seen in the stomach
all known mammalian glycosyltransferases (Schachter,(Figure 1A). These observations imply that core2-inde-
1994). In vitro, a soluble form of the protein addspendent glycans are responsible for the potent residual
N-acetylglucosamine to the core1 Gal1→3GalNAc1→R,L-selectin ligands expressed in Core2GlcNAcT-I mice.
leading us to designate the enzyme Core1-3GlcNAcTTo define the oligosaccharide structures remaining in
(Figure 2). It is noteworthy that the enzyme can also addHEV from Core2GlcNAcT-I mice, MECA-79-positive
N-acetylglucosamine to core2 Gal1→3(GlcNAc1→glycoproteins were isolated from metabolically labeled
6)GalNAc1→R (Figure 2), indicating that core1 extensionwild-type and Core2GlcNAcT-I lymph node. Analysis
can occur after the core2 branch has been added, but noof [3H]-galactose-labeled glycoproteins from the spent
GalT activity was detected. The expression of Core1-medium revealed a major glycoprotein comigrating with
3GlcNAcT resulted in the expression of i antigen, Gal1→GlyCAM-1 (Figure 1B). The cell lysates yielded additional
4GlcNAc1→3Gal1→4GlcNAc→R, on HeLa cells (data[3H]-galactose-labeled L-selectin counterreceptors (Fig-
not shown), confirming the 1,3-N-acetylglucosaminyl-ure 1B).
transferase activity (Watanabe et al., 1979) of Core1-[3H]-Galactose-labeled glycoproteins from the spent
3GlcNAcT.medium, which consist primarily of GlyCAM-1, were then
subjected to structural analysis. After removal of sulfate
and sialic acid, HPLC analysis of O-linked oligosaccha- Core1-3GlcNAcT Is Expressed in HEV
Northern blot analysis demonstrated that Core1-rides derived from HEV of Core2GlcNAcT-I mice
showed a relatively simple profile compared with those 3GlcNAcT transcripts of 5.5 and 2.4 kb are expressed
in the small and large intestines and placenta (Figurefrom wild-type mice (Figures 1C and 1D). In particular, two
major oligosaccharides derived from Core2GlcNAcT-I 3A). The expression of Core1-3GlcNAcT in HEV was
demonstrated in a cell population enriched for MECA-mice (a and b) were different from core2 branch-containing
oligosaccharides. Oligosaccharide b was converted to oli- 79-positive HEV cells (Figure 3B). Using the same single-
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Figure 1. Oligosaccharide Biosynthesis in Core2GlcNAcT-I-Deficient Mice
(A) Core2GlcNAcT activity was measured for lymph nodes, stomach, and spleen isolated from wild-type (wt/wt) and Core2GlcNAcT-I null mice
(/).
(B) MECA-79-positive glycoproteins in culture medium and cell lysates, derived from [3H]-galactose-labeled lymph nodes, were subjected to
SDS-polyacrylamide gel electrophoresis followed by fluorography. GlyCAM-1 was immunoprecipitated from the culture medium with CAM02
antibodies (GlyCAM-1). The migration positions of GlyCAM-1 (GlyC), CD34, podocalyxin-like protein (PCLP), and Sgp200 are shown.
(C and D) O-Linked oligosaccharides were isolated from the glycoproteins shown in (B, middle panel), and subjected to HPLC analysis after
removal of sulfate and sialic acid.
(E, F, and G) HPLC analysis of peak b in (D) after sequential digestion with 1,3-specific fucosidase (E), followed by 1,4-specific galactosidase
(F), and -N-acetylglucosaminidase (G).
(H) Thin-layer chromatography analysis of partially O-methylated galactose derived from [3H]-galactose-labeled core2 branched O-glycan
produced peak f.
(I) The same analysis of compound b produced peaks e and f. f, e, d, and c are derived from terminal galactose, 3-O-substituted, 6-O-
substituted, and 3,6-di-O-substituted galactose, respectively.
stranded cDNA preparation, transcripts for LSST and detected in MECA-79-negative endothelial cells (Figures
3G and 3I).Core2GlcNAcT-I were also strongly detected, while
those for Core2GlcNAcT-II and -III were present in low
quantities (Figure 3B). Sulfated, Extended Core1 Oligosaccharide Is the
MECA-79 EpitopeIn situ hybridization revealed that Core1-3GlcNAcT
transcripts colocalize with PNAd expression in HEV, and CHO cells do not express MECA-79 reactivity and do
not express core2 branched O-glycans or extendedwere also identified in lymphoid cells (Figures 3C and
3E). By contrast, no Core1-3GlcNAcT transcripts were core1 O-glycans (Bierhuizen and Fukuda, 1992). Trans-
Cell
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Figure 2. Acceptor Specificity of Core1-
3GlcNAcT
Incorporation of 3H-GlcNAc from UDP-
[3H]GlcNAc to various acceptors by a soluble
Core1-3GlcNAcT. The activity from the me-
dium derived from mock-transfected cells
and a soluble Core1-3GlcNAcT is shown.
pNP, p-nitrophenol.
fection of CHO cells with Core2GlcNAcT-I and human sulfotransferases in conferring MECA-79 reactivity when
coexpressed with Core1-3GlcNAcT. Other sulfotransf-LSST did not yield MECA-79 antigen (Hiraoka et al.,
1999), indicating that core2 O-glycans are neither neces- erases including mouse and human GlcNAc6ST and hu-
man intestine GlcNAc6ST (Lee et al., 1999) did not confersary nor sufficient for elaboration of MECA-79-reactive
molecules. MECA-79 reactivity when coexpressed with Core1-
3GlcNAcT.In contrast, CHO cells transfected with Core1-
3GlcNAcT and human LSST expressed MECA-79 reac- To define the counterreceptor requirements for
MECA-79 epitope display, Core1-3GlcNAcT and hu-tivity, whereas CHO cells transfected with either enzyme
alone were negative for MECA-79 expression (Figure man LSST were expressed in CHO cells together with
soluble CD34, GlyCAM-1, MAdCAM-1, or NCAM chime-4A). Human LSST and, to a lesser extent, mouse LSST
were alone among the available cloned GlcNAc-6-O- ric proteins. Analysis of released soluble chimeric pro-
Figure 3. Expression of Transcripts for Core1-3GlcNAcT in Various Tissues and HEV
(A) Northern analysis of Core1-3GlcNAcT transcripts using human multiple tissue blots.
(B) Polymerase chain reaction was carried out using templates of single-stranded cDNAs constructed from MECA-79-positive (HEV) and
-negative (HEV) cells, and using plasmid harboring full-length cDNA of the enzymes indicated. All products separated by 2% agarose gel
electrophoresis were of the predicted size.
(C–J) Expression of Core1-3GlcNAcT transcripts and MECA-79 antigen in serial sections of human palatine tonsil HEV (C–F) and endothelial
cells (G–J). In situ hybridization with antisense (C and G) and sense (D and H) probes for Core1-3GlcNAcT and staining by MECA-79 antibody
(E and I) and control antibody (F and J) are shown. Bar  100 m.
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Figure 4. The MECA-79 Epitope Is 6-Sulfo Extended Core1 Oligosaccharide
(A) CHO cells expressing CD34 were transiently transfected with vectors encoding Core1-3GlcNAcT and LSST and subjected to indirect
immunofluorescent staining with MECA-79 antibody.
(B) CHO cells were transfected with vectors encoding LSST, Core1-3GlcNAcT, and IgG chimeras of CD34 (CD34), GlyCAM-1 (GlyC), MAdCAM-1
(MAdC), or NCAM (NCAM) in the absence () or presence () of 100 mM chlorate. Equivalent amount of released chimeric proteins, estimated
by Western analysis using anti-human IgG antibodies, was subjected to SDS-polyacrylamide gel electrophoresis and Western analysis using
the MECA-79 antibody.
(C) Binding of MECA-79 antibody to MECA-79-positive CD34•IgG coated on plates was measured in the absence and presence of synthetic
oligosaccharides, shown at right, at different concentrations.
teins demonstrated that MECA-79 antigen is displayed NCAM•IgG chimeric protein containing only N-glycans
(Angata et al., 2001) did not support MECA-79 expres-by CD34, GlyCAM-1, and MAdCAM-1, and is diminished
when sulfation is inhibited (Figure 4B). By contrast, the sion regardless of its state of sulfation (Figure 4B). It
Cell
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Figure 5. Structures of Sulfated Oligosaccharides Isolated from CHO Cells Transfected with Core2GlcNAcT-I, Core1-3GlcNAcT, or Both
CHO cells were stably transfected with vectors encoding Fuc-TVII, LSST, and CD34. Those transfected cells were further stably transfected
with Core2GlcNAcT-I or Core1-3GlcNAcT alone, or with both. To those CHO cells, GlyCAM-1•IgG was transiently expressed in the presence
of [3H]-galactose and [35S]-sulfate. Structures of sulfated oligosaccharides in the released GlyCAM-1•IgG were determined and shown. 6-sulfo
sLex and sLex are shown in orange and green, respectively. Neu, sialic acid.
is noteworthy that MAdCAM-1 expressed only a very and that the sialylated and sialylated, fucosylated forms
retain MECA-79 reactivity.small amount of MECA-79 antigen compared to CD34
or GlyCAM-1, indicating that MAdCAM-1 may not be a These results are consistent with previous studies
showing that sialic acid and fucose are not integral partsgood acceptor for Core1-3GlcNAcT.
of the MECA-79 epitope (Hemmerich et al., 1994; MalyTo further confirm and refine the requirements for the
et al., 1996). The results are also consistent with previousMECA-79 reactivity, oligosaccharides derived from the
findings that the MECA-79 antibody can inhibit lympho-extended core1 glycan were chemically synthesized.
cyte homing without prior removal of sialic acid or fu-MECA-79 antibody binding was efficiently inhibited by
cose (Streeter et al., 1988; Clark et al., 1998).a 6-sulfo extended core1 oligosaccharide, Gal1→
4(sulfo→6)GlcNAc1→3Gal1→3GalNAc1→octyl, and
its sialylated or sialylated, fucosylated form, NeuNAc2→ Core1-3GlcNAcT Together with Core2GlcNAcT-I
3Gal1→4[Fuc1→3(sulfo→6)]GlcNAc1→3Gal1→ Confer the Synthesis of Twin 6-Sulfo sLex
3GalNAc1→octyl (Figure 4C). The 6-sulfo group and in Biantennary O-Glycans Containing Both
core1 structure are absolutely required since neither Core1 Extension and Core2 Branch
nonsulfated, extended core1 oligosaccharide nor sul- Structural analyses of GlyCAM-1•IgG-associated sul-
fated N-acetyllactosamine lacking core1 inhibited fated glycans were completed to define the chemical
MECA-79 antibody binding (Figure 4C). The terminal ga- nature of the sulfated oligosaccharides directed by
lactose in the N-acetyllactosaminyl core1 is part of the Core1-3GlcNAcT and LSST. We established CHO
epitope since its agalacto form needs more than a ten cell lines stably transfected with CD34, fucosyltrans-
times concentration to achieve equivalent inhibition (Fig- ferase-VII (FucT-VII), and LSST, plus Core1-3GlcNAcT,
ure 4C). These results indicate that the minimum epitope Core2GlcNAcT-I, or both. Structures of [35S]-sulfate- and
of MECA-79 is the sulfated, extended core1 structure [3H]-galactose-labeled GlyCAM-1•IgG-derived glycans
generated in CHO cells expressing Core2GlcNAcT wereGal1→4(sulfo→6)GlcNAc1→3Gal1→3GalNAc1→R,
Novel Sulfated L-Selectin Oligosaccharide Ligands
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Figure 6. Analysis of Sulfated sLex Containing O-Linked Oligosaccharides Attached to GlyCAM-1
Radiolabeled GlyCAM-1•IgG isolated from CHO cells stably expressing Fuc-TVII, CD34, LSST, Core2GlcNAcT-I, and Core1-3GlcNAcT (A, B,
and C), and MECA-79-positive GlyCAM-1 isolated from wild-type mouse lymph nodes (D, E, and F). (A and D) Sephadex G-50 gel filtration of
O-glycans derived from GlyCAM-1•IgG released from the CHO cells (A) and GlyCAM-1 from HEV of wild-type mice (D). (B and E) QAE-
Sephadex chromatography of desialylated O-glycans from panel A (B) and panel D (E). Q1 and Q2 eluted with 70 mM and 120 mM NaCl,
respectively. (C and F) Bio-Gel P-4 gel filtration of peak Q1 in panel B (C) and panel E (F).
determined as described previously (Hiraoka et al., 1999) In parallel, HEV-derived [3H]-galactose-labeled
GlyCAM-1 from wild-type mouse lymph node was sub-and shown as structure 1 in Figure 5. Similar analysis of
O-glycans from GlyCAM-1•IgG generated in CHO cells jected to carbohydrate structural analysis. Monosul-
fated oligosaccharides (Q1 in Figure 6E) yielded peaksexpressing Core1-3GlcNAcT showed that the major
O-glycans are monosialylated extended core1 containing 4 and 6 (Figure 6F). Sequential glycosidase digestion
showed that peaks 4 and 6 contain almost all 6-sulfo6-sulfo sLex, shown as structure 2 in Figure 5. As a minor
component, poly-N-acetyllactosaminyl extended core1 sLex in core 2 branch, shown as structures 1 and 5 in
oligosaccharides shown as structure 4 in Figure 5 are Figure 5, respectively. The majority of 6-sulfo sLex in
present. By contrast, HEV-derived GlyCAM-1 from extended core1 is contained in biantennary O-glycans
Core2GlcNAcT-I mice contains predominantly struc- having twin 6-sulfo sLex shown as structure 7 in Figure
ture 2 in Figure 5 (see Figure 1). 5, which was recovered in Q2 (Figure 6E). These results
Monosulfated O-glycans in GlyCAM-1 derived from indicate that HEV of wild-type mice contain 6-sulfo-sLex
Core1-3GlcNAcT- and Core2GlcNAcT-I-transfected on core2 branched O-glycans, and on biantennary
CHO cells (Q1 in Figure 6B) produced peaks 4 and 6 O-glycans (structures 1, 5, and 7 in Figure 5).
after Bio-Gel P-4 gel filtration (Figure 6C). Sequential
glycosidase treatment showed that peak 4 is a mixture
6-Sulfo sLex in Extended Core1 O-Glycansof structure 1 and structure 2 in Figure 5 in a ratio of
Function as L-Selectin Ligands25:1 (see also Experimental Procedures). Similar analy-
To directly determine the role of Core1-3GlcNAcT insis showed that peak 6 (Figure 6C) was found to be
L-selectin ligand functionality, rolling and tethering ofa mixture of biantennary O-glycans having both core2
lymphocytes was assayed on CHO cells expressingbranch and core1 extension, structures 5 and 6 in Figure
6-sulfo sLex in different backbones of O-glycans. CHO5. Peak 6 also contained poly-N-acetyllactosaminyl oli-
cells expressing 6-sulfo sLex within extended core1 orgosaccharides, structures 3 and 4 in Figure 5. Using a
core2 oligosaccharides consistently yielded lymphocytesimilar approach, disulfated oligosaccharides Q2 (Fig-
adhesion in excess of the parent cell line lacking theseure 6B) were found to be biantennary O-glycans con-
oliogsaccharides (Figure 7A). CHO cells expressing bothtaining twin 6-sulfo sLex groups (structure 7 in Fig-
ure 5). Core2GlcNAcT-I and Core1-3GlcNAcT yielded signifi-
Cell
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Figure 7. L-Selectin-Mediated Adhesion on CHO Cells Expressing 6-Sulfo sLex on Different O-Glycans and on GlyCAM-1 from Wild-Type or
Core2GlcNAcT-I Mice
(A) CHO cells stably expressing CD34, LSST, and Fuc-TVII (open square) were further stably transfected with Core1-3GlcNAcT (open circle),
Core2GlcNAcT-I (filled diamond), or both Core1-3GlcNAcT and Core2GlcNAcT-I (filled triangle), grown on polystirene dishes, and used as
the bottom plate of a parallel flow chamber. The number of tethering and rolling lymphocytes at different shear forces is shown. Four
independent experiments produced almost identical results, and one representative experiment is shown.
(B and C) Lymphocyte rolling was measured on plates coated with GlyCAM-1 preparations from wild-type (wild-type) and Core2GlcNAcT-I
(C2GlcNAcT) mice, providing equivalent rolling in the different plates at the shear stress of 2.5 dynes/cm2. These plates were treated with
different concentrations of MECA-79 antibody and then assayed for lymphocyte adhesion. Two independent experiments produced almost
identical results and one representative experiment is shown. Standard deviations are shown.
cantly greater lymphocyte adhesion than 6-sulfo sLex whereas virtually all adhesion to Core2GlcNAcT-I
GlyCAM-1 is inhibited (Figures 7B and 7C). These resultsexpressed in either extended core1 oligosaccharides
or core2 branched oligosaccharides alone (Figure 7A). indicate that MECA-79-reactive 6-sulfo extended core1
structures account for almost all of the L-selectin ligandsThese results indicate that Core1-3GlcNAcT contrib-
utes to the synthesis of L-selectin ligands, and infer that in the Core2GlcNAcT-I mouse, and a large portion of
the L-selectin ligands in the wild-type mouse.biantennary oligosaccharides containing both extended
core1 and core2 branches can, under some circum-
stance, operationally synergize to promote optimal Discussion
L-selectin ligand activity.
To determine the contribution of extended core1 Structures of oligosaccharide ligands that are elabo-
rated by HEV have remained elusive despite the cloningO-glycans to L-selectin counterreceptor activity, we iso-
lated GlyCAM-1 from the serum of Core2GlcNAcT-I and and analysis of numerous putative L-selectin counterre-
ceptors. Ablation of counterreceptors such as GlyCAM-1wild-type mice, and used it as an adhesion substrate in
parallel plate flow chamber assays. In experiments and CD34 has not been useful in defining these oligo-
saccharides due to the number of highly glycosylatedwhere the amounts of wild-type and Core2GlcNAcT-I
GlyCAM-1 were adjusted to yield equivalent lymphocyte HEV proteins which carry the same functional oligosac-
charides (Suzuki et al., 1996; Kansas, 1996). To addressadhesion under shear, we found that adhesion on
Core2GlcNAcT-I GlyCAM-1 was more susceptible to this problem, we have defined the structures of the HEV-
derived oligosaccharides isolated from wild-type mice,inhibition by MECA-79 antibody, relative to wild-type
GlyCAM-1, throughout a range of MECA-79 antibody and from mice that sustain a deletion of Core2GlcNAcT-I,
a key glycosyltransferase implicated in L-selectin ligandconcentrations. At the highest antibody concentrations
used (2 and 4 g/ml), a significant fraction of lympho- formation (Ellies et al., 1998). Although lymphocyte hom-
ing is largely retained in Core2GlcNAcT-I-deficient mice,cytes continue to adhere to wild-type GlyCAM-1,
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Figure 8. Structure and Biosynthesis of L-selectin Ligand Oligosaccharides
Core1 O-glycans can be extended by Core1-3GlcNAcT and then sulfated by LSST. The resultant oligosaccharide can be galactosylated to
form the minimum epitope for MECA-79 antibody. The galactosylated oligosaccharide is further sialylated and fucosylated to form 6-sulfo
sLex in the extended core1, which is also MECA-79 positive (right). Core1 oligosaccharides can be converted to core2 O-glycans by Core2-
GlcNAcT. Core2 oligosaccharides may be sulfated by LSST, galactosylated and sialylated, and fucosylated to form 6-sulfo sialyl Lewis x in
core2 O-glycans (second from right). Core1 sialylation is mostly carried out by ST3Gal-I (Priatel et al., 2000). Core2GlcNAcT does not act on
extended core 1 structures, but Core1-3GlcNAcT can act on core2 branched O-glycans, leading to biantennary O-glycans containing both
core2 branch and core1 extension (left half). All of these processed O-glycans function as L-selectin ligands. 4Gal-T, 1,4-galactosyltransfer-
ase; ST3Gal, 2,3-sialyltransferase; Fuc-TVII, fucosyltransferase VII.
analysis of the remaining oligosaccharide structures has branched oligosaccharides were detected in HEV of
Core2GlcNAcT-I mice. Indeed, adhesion of lympho-allowed us to define sulfated extended core1 mucin-
type O-glycans as the novel L-selectin ligand required cytes on GlyCAM-1 prepared from Core2GlcNAcT-I
mice HEV is efficiently inhibited by MECA-79 antibody.for lymphocyte homing in the absence of core2 struc-
tures. By contrast, the same treatment significantly though
incompletely reduces the lymphocyte adhesion onIt has been demonstrated that sulfo sLex formed on
core2 branched O-glycans contributes to L-selectin li- GlyCAM-1 from wild-type mice HEV, being consistent
with that some of wild-type L-selectin ligand is derivedgands in HEV (Figure 8, second from right; Hiraoka et
al., 1999). In the present study, we have revealed a bio- from MECA-79-negative core2 branched O-glycans. Our
results indicate that deletion of Core2GlcNAcT-I is notsynthetic pathway that leads to the formation of 6-sulfo
sLex in O-glycans through the extension and modifica- compensated for by Core2GlcNAcT-II or -III, but that
core2-based oligosaccharides are functionally compen-tion of the core1 structure Gal1→3GalNAc (Figure 8,
far right and left half). The molecular cloning studies sated for by extended core1-based L-selectin ligands.
CHO cells doubly transfected with Core1-3GlcNAcTreported here identify Core1-3GlcNAcT as an exten-
sion enzyme that together with LSST directs expression and Core2GlcNAcT-I contain biantennary oligosaccha-
rides with twin 6-sulfo sLex, providing much betterof MECA-79 antigen. Sequential addition of 2,3-linked
sialic acid and 1,3-linked fucose to the MECA-79 mini- L-selectin binding compared to CHO cells expressing
either enzyme. GlyCAM-1 derived from wild-type micemum epitope leads to the formation of 6-sulfo sLex in
extended core1 structures, providing L-selectin ligand also contains biantennary O-glycans with twin 6-sulfo
sLex. These results suggest that biantennary O-glycans,functionality. In contrast, none of the other four 1,3-N-
acetylglucosaminyltransferases cloned to date (Sasaki in which both arms are substituted with 6-sulfo sLex and/
or sLex, may exhibit superior L-selectin ligand activityet al., 1997; Zhou et al., 1999; the present study) con-
ferred MECA-79 antigen expression (data not shown). characteristic of HEV in wild-type mice. It is possible
that L-selectin, like P-selectin (Ushiyama et al., 1993),Although Core2GlcNAcT-II and Core2GlcNAcT-III were
suggested to compensate for the loss of Core2GlcNAcT-I, is present in oligomeric forms on the cell surface. In-
deed, L-selectin molecules clustered on microvilli ex-only small amounts of Core2GlcNAcT-II and Core2-
GlcNAcT-III transcripts and virtually no sulfated core2 hibit more efficient tethering than those randomly ex-
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Experimental Procedurespressed (Stein et al., 1999). These considerations
suggest the possibility that the bivalent nature of bian-
Isolation of cDNA Encoding Core1-3GlcNAcTtennary O-glycans doubly substituted with twin 6-sulfo
A Blast search of the dbEST identified three query genes
sLex or 6-sulfo sLex and sLex moieties may contribute (#AB015630, #AA13340, and #W26453) homologous to the coding
to more effective engagement with clustered L-selectin region of 3GlcNAcT (Zhou et al., 1999). Using 5	-RACE, a 1.2 kb
fragment containing the full-length coding sequence for ESTmolecules, and thereby yield optimal shear-dependent
AB015630 was isolated from single-stranded cDNA from HT29 hu-lymphocyte adhesion.
man colonic carcinoma cells and then cloned into pcDNA3, formingAmong different L-selectin counterreceptors, MAd-
pcDNA3-Core1-3GlcNAcT. Similarly, full-length coding cDNA se-CAM-1 primarily plays a role in lymphocyte homing to
quences for AA13340 and W26453 were cloned into pcDNA3.
Peyer’s patches (Butcher and Picker, 1996). Our results
demonstrate that MAdCAM-1 acquires MECA-79 anti- In Vitro Assay of 3GlcNAcT Activity
gen inefficiently compared with CD34 or GlyCAM-1, and Using PCR primers matching the full-length sequence, a cDNA frag-
ment encoding the soluble catalytic domain of novel enzymes wasare consistent with previous reports that only a fraction
cloned into pcDNA3.1/HSH, encoding a signal peptide followed byof MAdCAM-1 molecules are decorated with the MECA-
a 6 His tag (Angata et al., 2001). Each vector harboring a novel cDNA79 antigen (Berg et al., 1993). Sulfation of MAdCAM-1
was transfected into CHO cells and the soluble enzyme released
in core2 branched O-glycans is, however, only slightly into the medium was assayed using UDP-[3H]GlcNAc and various
less efficient than sulfation of other counterreceptors synthetic receptors as described previously (Yeh et al., 1999). GalT
(Hiraoka et al., 1999). These results suggest that L-selec- activity was also assayed using UDP-[3H]Gal and GalNAc1→
p-nitrophenol or GlcNAc1→p-nitrophenol as an acceptor. Core2-tin binding to MAdCAM-1 in Peyer’s patches is not as
GlcNAcT activity was assayed as described previously (Bierhuizenstrong as L-selectin binding to lymph node counterre-
and Fukuda, 1992).ceptors such as CD34 due to insufficient amounts of
extended core1-based 6-sulfo sLex. These results are
Isolation of cDNA Encoding Human LSST
consistent with the observations that MECA-79 only A cDNA encoding a portion of human LSST was obtained by PCR
weakly stains HEV in Peyer’s patches, and that L-selec- using human genomic DNA and primers based on the nucleotide
tin plays a minor role in Peyer’s patches with both sequence of mouse LSST (Hiraoka et al., 1999). Using the PCR
procedure, a full-length genomic sequence was obtained by screen-L-selectin- and 47 integrin-mediated adhesion being
ing a P1 human genomic phage library (Genome Systems). Basednecessary for lymphocyte tethering and rolling (Bar-
on the genomic sequence, cDNA sequence was obtained by RT-gatze et al., 1995).
PCR using human lymph node poly(A) RNA and cloned into
Expression of Core1-3GlcNAcT transcripts was ob- pcDNA1.1, resulting in pcDNA1.1-human LSST. The nucleotide se-
served in cells that express MECA-79 antigen, but they quence was identical to that reported by Bistrup et al. (1999).
were also detected in cells negative for MECA-79 and
mucin-producing tissues. Core1-3GlcNAcT may also Synthesis of Core1-3GlcNAcT and Other
Glycosyltransferase cDNAs from MECA-79-Positive Cellsbe involved in the synthesis of core1 extended struc-
MECA-79-positive, high endothelial cells were isolated from humantures found in human colonic mucins (Capon et al.,
tonsil using the MECA-79 antibody as described (Girard and1997). MECA-79 antigen and L-selectin ligands are in-
Springer, 1995). Total RNA (120 ng) isolated from MECA-79-positive
duced on microvascular endothelium in chronic inflam- and -negative stromal cells was reverse transcribed and used for
matory states, insulitis in the nonobese diabetic mice and PCR templates as described previously (Hiraoka et al., 1999). Oligo-
nucleotide primer pairs were used for specific amplification of hu-rejection of the heart transplants (reviewed in Rosen,
man LSST (nucleotides 407–426 and 754–733), Core1-3GlcNAcT1999). LSST and Fuc-TVII transcripts are also induced
(nucleotides 628–654 and 1134–1104), Core2GlcNAcT-I (nucleotidesin MECA-79-positive HEV-like microvasculature in the
139–166 and 570–542), Core2GlcNAcT-II (nucleotides 331–357 andthymic hyperplasia of the AKR mouse (Hiraoka et al.,
577–550), Core2GlcNAcT-III (nucleotides 288–314 and 840–814), and
1999). These observations suggest that the HEV pheno- GlcNAc6ST (nucleotides 1333–1355 and 1863–1842).
type is associated with coordinated regulation of a se-
ries of enzymes that confer L-selectin counterreceptor In Situ Hybridization
In situ hybridization and immunohistochemical procedures wereactivity. Among these enzymes responsible for L-selec-
completed on human palatine tonsil as previously described (Hira-tin ligand synthesis, the expression of LSST is most
oka et al., 1999). Digoxigenin-labeled sense and antisense ribo-restricted to HEV, thereby restricting L-selectin ligand
probes were prepared by in vitro transcription from plasmid con-
expression in HEV. taining a segment of human Core1-3GlcNAcT (nucleotides
In conclusion, our observations demonstrate that a 704–854).
Gal1→4(sulfo→6)GlcNAc1→3Gal1→3GalNAc1→R
is a backbone structure for PNAd that is detected by Metabolic Labeling of Murine Lymph Nodes and Isolation
of MECA-79-Positive GlycoproteinsMECA-79. A newly cloned Core1-3GlcNAcT together
Murine axillary, brachial, cervical, and mesenteric lymph nodes fromwith LSST and Fuc-TVII confers the expression of
wild-type and Core2GlcNAcT-I mice were labeled in organ cultureL-selectin ligand on extended core1 oligosaccharides.
in Glc-free RPMI 1640 medium supplemented with 10% fetal calf
Moreover, the synthesis of biantennary oligosaccha- serum containing 0.5 mCi/ml [3H]-galactose. The conditioned me-
rides containing both core2 branches and core1 exten- dium was applied to MECA-79 antibody conjugated to UltraLink
Biosupport Medium (Pierce) and eluted as described previouslysions exhibits a synergistic effect on L-selectin-depen-
(Hemmerich et al., 1994). Similarly, metabolically labeled cell pelletsdent cell adhesion activity. These observations and the
were lysed in 1% Triton X-100 in PBS and subjected to MECA-79expression of Core1-3GlcNAcT in HEV indicate that
antibody column chromatography.
Core1-3GlcNAcT together with Core2GlcNAcT-I and
LSST provide a primary contribution to the synthesis of Transient Transfection and MECA-79 Antigen Expression
HEV-borne L-selectin ligands and the homing of lympho- cDNAs encoding IgG chimera of CD34, GlyCAM-1, MAdCAM-1, or
NCAM were constructed and transiently cotransfected with humancytes to secondary lymphoid organs.
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LSST and Core1-3GlcNAcT cDNAs to CHO cells as described pre- been coated with anti-GlyCAM-1 antibodies, CAM02 (Bruehl et al.,
2000). The amount of GlyCAM-1 from wild-type or Core2GlcNAcT-Iviously (Hiraoka et al., 1999). Released, purified chimeric proteins
were subjected to Western analysis with MECA-79 antibody as de- mice was adjusted to provide equivalent lymphocyte adhesion.
Once we obtained these two plates, they were divided and treatedscribed before (Berg et al., 1993).
with different concentrations of MECA-79 antibody before rolling
assays.Transfection and Metabolic Cell Labeling
Lymphocytes were initially introduced into the flow chamber at aCHO cells were stably transfected with CD34, Fuc-TVII, and human
wall shear stress of 5 dynes/cm2 for 15 s, followed by the terminationLSST. Cells expressing sialyl Lewis x and CD34 were selected after
of flow to allow the cells to adhere under static conditions. Flowimmunostaining. Cells expressing LSST were then sorted for MECA-
rate was then reinitiated at the shear forces indicated in Figure 7.79-positive staining when they were transiently transfected with
Image analysis was performed and analyzed as described (Ellies etCore1-3GlcNAcT. These cells were further stably transfected with
al., 1998).Core1-3GlcNAcT or Core2GlcNAcT-I alone or with both. Those
cells expressing Core1-3GlcNAcT and Core2GlcNAcT-I were iso-
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